164 related articles for article (PubMed ID: 18475152)
1. Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes.
Marino F; Guasti L; Cosentino M; Rasini E; Ferrari M; Maio RC; Loraschi A; Cimpanelli MG; Schembri L; Legnaro M; Molteni E; Crespi C; Crema F; Venco A; Lecchini S
J Hypertens; 2008 Jun; 26(6):1147-55. PubMed ID: 18475152
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin.
Marino F; Guasti L; Cosentino M; Ferrari M; Rasini E; Maio RC; Cimpanelli MG; Cereda E; Crespi C; Simoni C; Restelli D; Venco A; Lecchini S
J Cardiovasc Pharmacol; 2007 May; 49(5):299-305. PubMed ID: 17513949
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study.
Rasini E; Cosentino M; Marino F; Legnaro M; Ferrari M; Guasti L; Venco A; Lecchini S
Regul Pept; 2006 May; 134(2-3):69-74. PubMed ID: 16530863
[TBL] [Abstract][Full Text] [Related]
4. Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up.
Guasti L; Marino F; Cosentino M; Maio RC; Rasini E; Ferrari M; Castiglioni L; Klersy C; Gaudio G; Grandi AM; Lecchini S; Venco A
Eur Heart J; 2008 May; 29(9):1118-26. PubMed ID: 18390537
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
8. Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients.
Sardo MA; Mandraffino G; Riggio S; D'Ascola A; Alibrandi A; Saitta C; Imbalzano E; Castaldo M; Cinquegrani M; Saitta A
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):933-8. PubMed ID: 20497421
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes.
Coppo M; Boddi M; Bandinelli M; Degl'innocenti D; Ramazzotti M; Marra F; Galastri S; Abbate R; Gensini GF; Poggesi L
Regul Pept; 2008 Nov; 151(1-3):1-6. PubMed ID: 18723052
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor mRNA expression and vasoconstriction in human coronary arteries: effects of heart failure and age.
Wackenfors A; Pantev E; Emilson M; Edvinsson L; Malmsjö M
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):266-72. PubMed ID: 15569271
[TBL] [Abstract][Full Text] [Related]
11. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
12. Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma.
Hodroj W; Legedz L; Foudi N; Cerutti C; Bourdillon MC; Feugier P; Beylot M; Randon J; Bricca G
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):525-31. PubMed ID: 17170378
[TBL] [Abstract][Full Text] [Related]
13. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
14. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease.
Marino F; Guasti L; Tozzi M; Consuelo Maio R; Castiglioni L; Rasini E; Schembri L; Maroni L; Legnaro M; De Leo A; Piffaretti G; Castelli P; Venco A; Lecchini S; Cosentino M
J Cardiovasc Pharmacol; 2009 Dec; 54(6):520-5. PubMed ID: 19755917
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin regulates non-neuronal cholinergic activity in T lymphocytes via CD11a-mediated pathways.
Fujii T; Masuyama K; Kawashima K
J Neuroimmunol; 2006 Oct; 179(1-2):101-7. PubMed ID: 16828882
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin therapy normalizes sympathetic neural control in experimental heart failure: roles of angiotensin II type 1 receptors and NAD(P)H oxidase.
Gao L; Wang W; Li YL; Schultz HD; Liu D; Cornish KG; Zucker IH
Circulation; 2005 Sep; 112(12):1763-70. PubMed ID: 16157767
[TBL] [Abstract][Full Text] [Related]
18. Meconium increases type 1 angiotensin II receptor expression and alveolar cell death.
Rosenfeld CR; Zagariya AM; Liu XT; Willis BC; Fluharty S; Vidyasagar D
Pediatr Res; 2008 Mar; 63(3):251-6. PubMed ID: 18287962
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
Mikael LG; Rozen R
Cardiovasc Res; 2008 Oct; 80(1):151-8. PubMed ID: 18540024
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein reduction by simvastatin is accompanied by angiotensin II type 1 receptor downregulation, reduced oxidative stress, and improved endothelial function in patients with stable coronary artery disease.
Kiliszek M; Maczewski M; Styczyński G; Duda M; Opolski G; Beresewicz A
Coron Artery Dis; 2007 May; 18(3):201-9. PubMed ID: 17429294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
